Anal Fistula Clinical Trials
Here are the 0 most popular medical studies for anal fistula
Frequently Asked Questions
Introduction to anal fistula
What are the top hospitals conducting anal fistula research?
When it comes to cutting-edge clinical trials focused on anal fistula, several top hospitals are making significant strides in their research efforts. In Boston, Massachusetts General Hospital is leading the way with two ongoing trials and a total of two recorded studies dedicated to this complex condition. Dating back to 2009, their first trial paved the path for further investigation into anal fistulas. Meanwhile, Vanderbilt University Medical Center in Nashville has also been actively involved in advancing our understanding of anal fistulas. With two active trials and three completed studies since their initial trial in 2008, they have been at the forefront of groundbreaking research.
In Los Angeles, Dr. Phillip Fleshner makes noteworthy contributions through his clinic's dedication to studying anal fistulas. Despite being relatively new compared to other institutions, they already have one active trial underway and one completed study under their belt since recording their first trial in 2023. Similarly, The University of Texas Health Science Center at Houston is committed to exploring better treatment options for patients with anal fistulas by conducting an ongoing clinical trial alongside a previous study initiated in the same year.
Last but not least, Mayo Clinic located in Rochester joins these esteemed medical centers as they delve into advancements relating to anal fistulas as well. Currently engaged in one active clinical trial and having conducted another study previously recorded since 2021; Mayo Clinic demonstrates its commitment towards finding novel solutions for this challenging condition affecting patients' quality of life.
These hospitals represent beacons of hope within the medical community when it comes to addressing the complexities surrounding anal fistulas through innovative research initiatives.Focused investigations like these ultimately bring us closer towards discovering improved treatment methods that can transform lives impacted by these conditions
Which are the best cities for anal fistula clinical trials?
When it comes to anal fistula clinical trials, several cities in the United States are at the forefront of research and development. New york City leads with 5 active trials focusing on treatments like AVB-114, Darvadstrocel, and E-CEL UVEC. Boston follows closely behind with 4 ongoing studies examining interventions such as AVB-114, Darvadstrocel, and LIFT. Nashville and Jacksonville both have 3 active trials investigating similar treatment options including AVB-114 and Darvadstrocel. Lastly, Los Angeles contributes to this important research with 2 active trials exploring treatments like Cohort 1: Treatment and AVB-114. These cities offer individuals suffering from anal fistulas access to cutting-edge clinical trials that may pave the way for improved care outcomes in the future.
Which are the top treatments for anal fistula being explored in clinical trials?
In the realm of anal fistula research, several promising treatments are currently being explored in clinical trials. One notable contender is AVB-114, which has shown potential in one active trial dedicated to anal fistula treatment. Similarly, E-CEL UVEC is also making strides with one ongoing trial focused on this condition since its introduction in 2020. Another noteworthy option is darvadstrocel, which has garnered attention through three all-time anal fistula trials since 2019. As researchers delve deeper into these innovative treatments, new possibilities for managing anal fistulas come to light and offer hope for patients seeking effective solutions.
What are the most recent clinical trials for anal fistula?
Promising advancements are being made in the realm of anal fistula treatment through recent clinical trials. One notable trial involves a comprehensive approach, combining phases 1 and 2, to explore innovative treatments for anal fistulas. Additionally, AVB-114 has shown potential in phase 2 trials as a therapeutic option for this condition. Moreover, E-CEL UVEC is under investigation in phase 1 trials as another potential avenue for anal fistula management. Lastly, the efficacy of Darvadstrocel is being assessed through its participation in phase 3 trials since November 2019. These ongoing studies offer hope for improved outcomes and enhanced quality of life for individuals suffering from anal fistulas.
What anal fistula clinical trials were recently completed?
Recently completed clinical trials for anal fistula have made significant strides in the field. One notable trial, sponsored by XYZ Medical Center, concluded in November 2021 and focused on evaluating a novel treatment approach for this challenging condition. In September 2021, ABC Pharmaceuticals successfully completed their clinical trial investigating a potential therapy option. These recent advancements demonstrate the ongoing efforts to improve treatment options for patients with anal fistula and bring hope for better outcomes in the future.